Face masks must still be worn in NHS buildings
To protect patients, visitors and our staff, all visitors to our sites must continue to wear a face mask (unless exempt). Face masks and hand sanitiser are available at the entrances to all our sites.
Local Research News
HWHCT Research Newsletters
April 2022: April 2022 update.pdf [pdf] 738KB
February 2022: February 2022 update.pdf [pdf] 324KB
December 2021: Research newsletter Christmas 2021.pdf [pdf] 4MB
CQC Preparation: Research-Ready Packs (end of April/May 2022)
Keen to spread the word about research but also to support staff ahead of a future CQC visit, the Research Team have posted out ‘Getting Research Ready’ packs to all Trust sites. These packs offer varying levels of information for both staff and patients including posters and leaflets to display in patient facing areas and quick guides for staff. The overview sheet in the pack gives a bit of background and explains what’s included. Please email us if you require further copies of anything that’s in the packs or if you have any questions.
Worcester University's Feel Good Fayre in celebration of University Mental Health Day: 15.3.22
We were really pleased to have been invited to the Feel Good Fayre at Worcester University on Tuesday 15 March 2022 and what a day it was! Our first F2F off site research promotional day this year and once again we were wowed by the the students' interest and openness whilst chatting about mental health research. We handed out over 80 goody bags with research information and a few goodies enclosed, and the GLAD study (genetic links to anxiety and depression) QR code was scanned countless times.
It was also great to catch up with colleagues from the sexual health and early intervention in Psychosis teams who were also there.
Local participation in national research study published 21.12.21
Huge congratulations to Marti van der Linde (Community Paediatric Dietitian Worcestershire North) who, as part of a team, had their work published online in 'Nutrition in Clinical Practise' just before Christmas. This was a commercial study run by Nestle and looked to 'Monitor gastrointestinal tolerance in children who have switched to an “enteral formula with food-derived ingredients”: A national, multicenter retrospective chart review (RICIMIX study).'
To read the article and outcomes in full please click here.
Evidence Based Practice (EBP) Conference: 16-18 November 2021
Our inaugural research/EBP virtual conference was a huge success! We had 41 people attend at least 1 of the sessions and the feedback so far has been great. Huge HUGE thanks to everyone that attended and to our wonderful presenters without whom this event wouldn’t have taken place:
- Simon Meadows (Clinical Lead Physiotherapist)
- Simone van Dalen (Physiotherapy Team Leader)
- Clare McFadyen (OT at New Haven)
- Rosie Callaghan (Tissue Viability Lead Nurse)
- Martha van der Linde (Community Paediatric Dietitian)
- Chrissy Walker (OT Neighbourhood Team 1)
- Alice Turnbull (Service Lead for Paediatric OT and Physiotherapy)
- Emma Jesic (Specialist Paediatric OT & OT Lead for Neurodevelopment)
- Nicola Bundy (CAMHS Practitioner)
- Abigail Matthews (OT in Hereford Neighbourhood Mental Health Service)
- Dr Kerry Gaskin (Head of Department - Midwifery and CPD; Principal Lecturer in Advanced Clinical Practice,from the University of Worcester)
- Cliff Lewis (Advanced Physiotherapy Practitioner)
Your insightful presentations gave us all food for thought and really demonstrated how staff from all across HWHCT are constantly striving to improve patient care. Thank you.
Promoting health research off-site, Autumn 2021:
It has been so good to get out and about meeting people face to face and talking about health research over the last few months. Those who follow us on twitter (@HWHCT_Research) will have seen we’ve visited Worcester Woods a couple of times, joined other departments at the Health Care Assistant (HCA) conference on 17 September and engaged with students at Worcester University in the Students Union. It has been great to get to talk to members of the general public about health research and how easy it is for anyone to get involved at some level. Join Dementia Research (https://www.joindementiaresearch.nihr.ac.uk/) and keeping an eye out for our online survey questionnaires are great ways to do this.
We hope to do some more off-site research research promotion in the new year so keep an eye on our twitter page to see where we'll be.
World Alzheimer’s awareness month: September 2021
September is World Alzheimer’s awareness month #WorldAlzMonth which we really wanted to get behind and promote. We asked a number of people who work in Alzheimer's research or with Alzheimer's patients for their viewpoints including key points that they wanted to highlight about the disease: why taking part in research is so important, what does Alzheimer’s research do, and how to get involved. A huge thank you to our contributors: Mella McCarthy (HWHCT), Nathan Stephens (Uni of Worcester), Jackie Smart (Research Facilitator, NIHR Clinical Research Network) and Julia Ravey (Alzheimer’s Society). Plus those who took part in Join Dementia Research (JDR) #passiton campaign by willingly(!) having their photo taken to be shared on twitter. Make sure you follow us on twitter @HWHCT_Research to find out more!
And don’t forget that one of the easiest ways to get involved in Alzheimer’s research is by signing up to Join Dementia Research (JDR) - an online service that connects registered volunteers with dementia researchers across the UK who are looking for people to join their studies. Healthy volunteers are needed too so ANYONE can sign up – go for it!
Psychological Impact of COVID-19 - intial results from phase 1 of the study (December 2021)
The Psychological Impact of COVID-19 (phase 1) looked at the psychological impact of the first lockdown, the relaxation of lockdown rules and the compulsory face coverings period. These inital results show the varying impacts of each of the above listed periods on different population sub groups - including gender, age, ethnicity and professional groups. Please click here to read the full article.
HUGE thanks to everyone who took part.
COPE-WM: Initial findings from this study were released 19.11.21
COPE-WM was a far reaching questionnaire study available to anyone who worked in healthcare. It closed at the end of September 2021.
The study released their initial findings on 19.11.21 which included:
- Unsurprisingly those healthcare employees who had a positive COVID-19 test result were more likely to provide direct care to patients with COVID-19
- There was poor infection control at the beginning of the pandemic but effective infection control measures were implemented after this initial period
- Experience of working during the pandemic:
- Demand as outstripping capacity
- Peer support at work was as important as ever
- Morally challenging decisions in the workplace
- Mixed re-deployment experiences
- Impact on mental health:
- Mental health deterioration experienced during the pandemic
- Uncertainty during the pandemic
- Mental health coping mechanisms disabled
- Working from home as problematic for mental health
- Positive antibody rates:
- Prior to vaccination 46% of participants had had a COVID infection (included study participants who had answered ‘yes’ as being symptomatic who then qualified to receive an antibody test kit)
- From December 2020 rates of antibody positivity rise dramatically following the 1st and 2nd dose of vaccination to 98+%
- A study coming in the new year – COCO – will further look into the issues raised here
They have only released preliminary findings including the above so we will share the full report once it’s released.
We’ve also received a request from the study regarding the follow up survey:
‘Thank you to everyone that took the time to complete the COPE-WM study baseline survey. If you completed the baseline survey and this was more than 4 months ago you should have received an email asking you to complete the follow up survey for the study. The email was sent to the email address you provided when asked for your personal email address when you completed the baseline survey. Thank you to everyone who has already completed their follow up survey.
Please be aware that for some participants the COPE-WM study emails have been filtered to their spam/junk folder – please check there if you think you should have received an email
If, however, you received a request email but have not yet completed the survey we would encourage you to do so to ensure your follow up data contributes to the study outcomes. Survey completion should take no more than 20 minutes of your time.
If you took part in the study more than 4 months ago and either have not received an email request to complete the follow up survey or remember receiving one but are no longer able to access it and would like to complete the survey please contact the study research team by email:
If you took part less than 4 months ago please keep an eye out for the email about the follow up that you should receive in the next few weeks.
The higher the number of participants who complete their follow up survey the better the study will be able to understand the impact of COVID-19 on people working in healthcare settings.’
THANK YOU once again to everyone who took part in this study.
iMCSP (individualised Meeting Centres Support Programme) – initial findings
We were involved in this research study a few years ago so please click below for the results: CIA_A_212852 1527..1553 (dovepress.com). Thank you to those who were involved.
SYMBAD trial results - October 2021
HWHCT took part in this trial so we were really pleased to receive these results at the end of October 2021. The main results have been published in the Lancet: https://authors.elsevier.com/sd/article/S0140673621012101 but please see below for the summary outcomes:
‘In summary we found that there was no benefit in taking mirtazapine compared with placebo, there was even the possibility of harm with a marginally higher rate of mortality in the mirtazapine group. The clear conclusion from the data is that they do not support the use of mirtazapine as a treatment for agitation in dementia. Positively there was clear recovery in those that participated in both the placebo and the mirtazapine group. This means that the best thing to do clinically may be to actively monitor agitation while carrying out treatment as usual, rather than jumping to use another medication in all but the most serious of cases.
This is a result that has important implications to clinical practice, and we hope that you will join with us in disseminating the findings as widely as possible. There has been a press release: Research news - Common antidepressant should no longer be used to treat people with dementia - University of Exeter by the University of Plymouth and the team would be happy to work with your local institutions and Trusts should you wish to provide further public information. Alzheimer’s Research UK has also published an article: Antidepressant drug doesn’t improve agitation in dementia trial - Alzheimer's Research UK (alzheimersresearchuk.org) ’
HUGE thanks to everyone who was involved in this study at HWHCT.
PrEP Impact Trial – A pragmatic health technology assessment and implementation.
PrEP (HIV Pre-exposure Prophylaxis) is a medicine for HIV negative people and it can reduce the risk of catching HIV when taken as instructed. However this is currently not available through the NHS.
PrEP is made up of two drugs, Tenofovir and Emtricitabine. Both these drugs have been widely used for many years to treat HIV and the drug has been used by several thousands of HIV negative people worldwide to reduce the risk of HIV.
To plan a PrEP programme in England, NHS England and Local Authorities carried out research to find out:
- How many people attending sexual health clinics need PrEP?
- How many of these start PrEP?
- How long do they need PrEP for?
In this Trust the study ran across the 3 Sexual Health Services; Arrowside, John Anthony Centre and Hereford and 64 patients were recruited. All participants in this study had access to PrEP.
This study has now closed but we will share the outcomes when they are published later this year. A huge thank you to everyone who was involved.
National Research news
Professional Training and Qualification updates
NHS Research and Development Forum newsletters
CRN (Clinical Research Network) Connect newsletters
CRN (Clinical Research Network) Network Update
Be Part of Research Newsletter
Research Design Service West Midlands (RDS WM) Newsletter
February 2022: click here
January 2022: click here
Thursday 22 December 2021: click here
NEW: Research Training PGCertificate - for September 2022 intake
This research training course prepares you for doctoral research. This could be in the social sciences, arts and humanities or in either the public or private sector.
The qualification meets the learning outcomes at certificate level in the national higher education qualifications framework. Click here to find out more.
NEW: 'What is health research?' - Free online course starting 16.5.22
'What is Health Research?' is aimed at anyone who wants to enhance their understanding of health research and covers how research improves healthcare, what health research involves, busts common myths and highlights ways to get involved. The course runs for three weeks and new learners can join at any time.
'Caring for people with psychosis and schizophrenia' - free course starting 6.6.22 running for 4 weeks
The course is developed specifically for carers/families and those with an interest in psychosis and caregiving issues. The course team comprise experts-by-experience in psychosis and caregiving and leading experts from nursing, psychiatry, pharmacy, psychology from across Kings Health Partners. The course is free for anyone across to join.
Click here to find out more and sign up.
Midlands Mental Health (MMH) and Neurosciences PHD Programme for Healthcare Professionals (21.3.22)
The Midlands hosts the most innovative centres in mental health and neurosciences (MH&N), including digital mental health, clinical trials, neuroimaging, and epidemiology, serving an area of huge clinical need.
The Midlands Mental Health & Neurosciences PhD Programme is led by the University of Nottingham, in collaboration with University of Birmingham, University of Leicester, and University of Warwick, and our local NHS Trusts in the Midlands.
Click here to find out more.
Leverhulme Trust Major Research Fellowships
For well-established, distinguished researchers in the humanities and social sciences to complete a piece of original research. Fellowships are particularly aimed at those who are or have been prevented by routine duties from completing a programme of original research.
Deadline for proposals: 13 May 2022
Find out more here
Associate Principle Investigator Scheme
The Associate PI Scheme is a six month in-work training opportunity, providing practical experience for healthcare professionals starting their research career.
People who would not normally have the opportunity to take part in clinical research in their day to day role have the chance to experience what it means to work on and deliver a NIHR portfolio trial under the mentorship of an enthusiastic Local PI. Click here for further information.
Research Seminars: organised by University of Worcester
Organised by the College of Health, Life and Environmental Sciences at University of Worcester, there is a fantastic schedule of free talks running through to the end of July 2022. For further information about the programme and for details about booking onto a seminar please click here.
National Research News
Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study (10.5.22)
COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from the NIHR-supported COV-BOOST study. Read more here.
Children could find it easier to reach a healthier weight if their parents are addressing their own weight (9.5.22)
New research funded by NIHR has found that many parents attending commercial weight management programmes would be happy for their child, if overweight, to also receive support to reach a healthier weight. Read more here.
People hospitalised with severe COVID-19 show cognitive decline similar to 20 years of ageing (5.5.22)
New research funded by NIHR shows that patients who were hospitalised with severe COVID have lasting cognitive problems several months after their acute illness. Read more here.
1,000 healthcare professionals take their first step in research as part of innovative NIHR scheme (29.4.22)
The NIHR is delighted to announce that over 1,000 health and care professionals have now got involved with research for the first time as part of the Associate Principal Investigator (PI) Scheme. Read more here.
Researchers create new tool to assess symptoms of long COVID (27.4.22)
Researchers have worked with patients to develop a comprehensive tool to assess the symptoms of long COVID and their impact on everyday life. Read more here.
COVID-19 vaccine boosters give well-maintained immunity three months on, finds NIHR-supported COV-BOOST trial (21.4.22)
The latest results from the UK’s COV-BOOST study, led by University Hospital Southampton, have shown prolonged immune responses following third doses of several COVID-19 vaccines. Read more here.
NIHR publishes framework to promote race equality in public involvement in research (20.4.22)
The NIHR is proud to publish our Race Equality Framework - a self-assessment tool to help organisations improve racial equality in public involvement in health and care research. Read more here.
Antiviral treatment Paxlovid investigated through PANORAMIC study (12.4.22)
The NIHR-supported PANORAMIC trial is investigating a new COVID-19 antiviral treatment, Paxlovid, among vulnerable groups in the community. Read more here.
Transforming care and health at home (12.4.22)
NIHR has co-funded 14 new research projects to develop technologies such as self-care apps, smart devices and wearables to help people transform their care and health at home. Read more here.
Major new mental health study inspired by lived experience (8.4.22)
Experts at Northumbria University are supporting a £1 million research study, funded by the NIHR, which aims to improve the outcomes and experiences of those being discharged from mental health hospitals. Read more here.
Landmark clinical trial shows benefits of virtual reality treatment for severe psychological problems (7.4.22)
The largest ever clinical trial of virtual reality (VR) therapy for mental health, funded by NIHR, has shown that automated VR treatment works well for patients diagnosed with psychosis. Read more here.
NIHR changes name to emphasise long-term commitment to social care research (5.4.22)
Since its establishment in 2006, the NIHR has invested over £200m in more than 470 social care research projects across its portfolio, with £90m worth of NIHR-funded social care studies starting in the last three years. Read more here.
NIHR publishes latest annual report (28.3.22)
The NIHR has published its latest annual report highlighting its milestones and achievements during 2020/21 - a year like no other. The report celebrates how NIHR responded to the COVID-19 pandemic while continuing to fund and support world-class and ground-breaking research. Read more here.
Covid-19 mixed with flu increases risk of severe illness and death (28.3.22)
Patients in hospital with both COVID-19 and flu are at much greater risk of severe disease and death, new NIHR-funded and supported research shows. Read more here.
Research suggests lithium could decrease the risk of developing dementia (21.3.22)
An analysis of patient health records suggests that lithium, usually prescribed for conditions such as bipolar disorder and depression, may lower the risk of developing dementia. Read more here.
Dementia patients struggle with change because of damage to general intelligence brain networks (18.3.22)
People with dementia struggle to cope with changes in their environment because of damage to areas of the brain known as ‘multiple demand networks’, an NIHR-supported study has revealed. Read more here.
NIHR unites with health and social care leaders to improve public involvement in research (11.3.22)
Funders, regulators and research organisations who play an important role in UK health and social care research have come together, working with members of the public, to sign up to a bold new shared commitment to improve public involvement in research. Read more here.
Genetic study gives further details into severe COVID-19 (7.3.22)
The world’s largest study of the genetics of critical COVID-19, has revealed details about some of the biological mechanisms behind the severe form of the disease. Read more here.
RECOVERY Trial shows baricitinib reduces deaths in COVID-19 hospitalised patients (3.3.22)
The NIHR-supported RECOVERY trial has found that baricitinib, an anti-inflammatory rheumatoid arthritis drug, reduces deaths in patients hospitalised for COVID-19 by around one-fifth. Read more here.